Текущие обязательства Изменить Дата
AbbVie USD 43.1B 1.46B 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Eli Lilly USD 47B 745M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Glaxosmithkline GBP 20.72B 1.71B 2026-09
Incyte USD 1.44B 125.72M 2026-09
J&J USD 55.46B 562M 2026-09
Merck USD 28.8B 1.07B 2026-09
Moderna USD 2.03B 506M 2026-09
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 29.77B 2.16B 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
United Therapeutics USD 624.3M 16.5M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09